Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy

Clinical trial NCT05770531 · RECRUITING

Trial details

NCT number: NCT05770531
Sponsor: Vanderbilt-Ingram Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic HER2-Negative Breast Carcinoma Metastatic Triple-Negative Breast Carcinoma

Start date: 2023-10-03
Primary completion: 2028-08-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.